Executive Summary
Generated July 30, 2026
Robotics
UBTECH Robotics
Strategic importance is our editorial rating of how central this entity is to the technology landscape we track; confidence reflects how well-sourced and current the underlying evidence is.
1
Chokepoint Score
1 other entity structurally depend on this one
Headquarters
Shenzhen, China
Website
Employees
2,000 (2024, approximate)
Founded
2012
Listing
9880 · Hong Kong Stock Exchange
Market Cap
HKD 41.03B
Revenue (TTM)
HKD 2.00B
Price
HKD81.5 (-2.34%)
Market data as of Jul 29, 2026, 11:25 AM · Source: Yahoo Finance (delayed). Not investment advice.
Overview
UBTECH Robotics is a Chinese humanoid robotics company developing AI-powered robots for industrial and consumer applications, positioned as one of China's most prominent entrants in the global race toward commercial humanoid robotics alongside Tesla's Optimus. Full-year 2025 revenue reached 2.001 billion yuan, up 53.3%, with humanoid robots becoming its largest single revenue source: 820 million yuan, up a startling 2,203.7% year-over-year, on 1,079 units sold — first globally by both humanoid revenue and volume. For 2026, UBTECH targets 10,000 units of annual humanoid production capacity and projects roughly 3.69 billion yuan in revenue, with analysts expecting profitability by 2027.
Strategic Connections
- AI Accelerators: UBTECH's humanoid robots use AI accelerator chips for on-device perception and control.
- Autonomous Systems & Robotics: UBTECH Robotics develops humanoid robots, introducing the mass-produced UWORLD U1 Series in June 2026.
- Robotics & Physical AI: UBTECH Robotics represents China's most prominent entrant in the global humanoid robotics race, developing AI-powered robots for industrial and consumer use.
- Doosan Robotics: Doosan Robotics operates in the broader robotics category alongside humanoid and industrial robotics makers like UBTECH Robotics, though focused on collaborative industrial robots.
- Unitree Robotics: UBTECH Robotics competes with Unitree Robotics as one of China's two most prominent humanoid robotics makers, both pursuing public listings and mass-market consumer humanoid products.
Strategic Risks
- Humanoid robotics remains an early-stage commercial category globally
Future Outlook
- Scaling industrial humanoid robot deployment in China
Sources
2 sources, 75% average source confidence — full citations in the Full Analyst Report.
Generated by InsightNodes — Technology Intelligence Platform. This report reflects sourced, evidence-backed information as of the dates cited above and is not investment advice.
Viewing the Executive Summary — switch to the Full Analyst Report.